Education
About Us
Working with TipRanks
Follow Us
Cloudbreak Pharma, Inc. (HK:2592)
:2592
2592 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$4.76 - HK$9.74
Previous CloseN/A
VolumeN/A
Average Volume (3M)604.17K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.15
Next Earnings
Aug 29, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding838,892,900
10 Day Avg. Volume402,464
30 Day Avg. Volume604,171
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Cloudbreak Pharma, Inc. News
2592 FAQ
What was Cloudbreak Pharma, Inc.’s price range in the past 12 months?
Cloudbreak Pharma, Inc. lowest stock price was HK$4.76 and its highest was HK$9.74 in the past 12 months.
What is Cloudbreak Pharma, Inc.’s market cap?
Currently, no data Available
When is Cloudbreak Pharma, Inc.’s upcoming earnings report date?
Cloudbreak Pharma, Inc.’s upcoming earnings report date is Aug 29, 2025 which is 27 days ago.
How were Cloudbreak Pharma, Inc.’s earnings last quarter?
Cloudbreak Pharma, Inc. released its earnings results on Aug 29, 2025. The company reported HK$0.085 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.085.
Is Cloudbreak Pharma, Inc. overvalued?
According to Wall Street analysts Cloudbreak Pharma, Inc.’s price is currently Overvalued.
Does Cloudbreak Pharma, Inc. pay dividends?
Cloudbreak Pharma, Inc. does not currently pay dividends.
What is Cloudbreak Pharma, Inc.’s EPS estimate?
Cloudbreak Pharma, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cloudbreak Pharma, Inc. have?
Cloudbreak Pharma, Inc. has 838,892,900 shares outstanding.
What happened to Cloudbreak Pharma, Inc.’s price movement after its last earnings report?
Cloudbreak Pharma, Inc. reported an EPS of HK$0.085 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.393%.
Which hedge fund is a major shareholder of Cloudbreak Pharma, Inc.?
Currently, no hedge funds are holding shares in HK:2592